Barely Significant
← all excerpts

Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761<sup>®</sup>.

CNS Neurosci Ther · 2019 · PMC6488894 · PMID 30648358

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
65 Interestingly, one study (GINDON study) showed a trend in favor of EGb 761 ® plus donepezil vs either agent alone, with regard to clinically meaningful cognitive functioning and global improvement. 55 Comparative data also demonstrated an improved safety profile with EGb 761 ® vs AChEIs and memantine. 65 3.6 Expert consensus/conclusion statements Herein, we summarize the Expert Panel's agreed consensus statements regarding the use of EGb 761 ® in the management of AD, VaD, BPSD, and MCI, along with other specific statements on clinically relevant issues (Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.